Sentences with phrase «year revenue growth due»

The social media company also warned of slowing year - over - year revenue growth due to a drop in ad prices.

Not exact matches

Due to longer manufacturer lead times, most of the additional fleet growth above our original forecast is expected to occur later in the year, positioning us well for revenue and earnings growth in 2019.

DTS earnings before tax of $ 13.1 million increased 16 % compared with $ 11.3 million in 2017, due to revenue growth and operating performance, as well as favorable developments related to self - insurance claims from prior years.

«While revenue for Q4 and FY18 was below expectations due to lower than anticipated smartphone unit volumes, Cirrus Logic made meaningful progress this past year on numerous strategic initiatives that we expect to position the company for a return to year - over-year growth in FY20,» said Jason Rhode, president and chief executive officer.

On Tuesday, reporting fourth quarter results, Verizon conceded that it would see no growth in wireless service revenue this year due to the increasingly fierce price wars roiling the market.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Growth in other revenue sources, such as Corporations Tax and Mining Tax, can differ significantly from growth in nominal GDP in any given year, due to the inherent volatility of business profits as well as the use of tax provisions, such as loss carGrowth in other revenue sources, such as Corporations Tax and Mining Tax, can differ significantly from growth in nominal GDP in any given year, due to the inherent volatility of business profits as well as the use of tax provisions, such as loss cargrowth in nominal GDP in any given year, due to the inherent volatility of business profits as well as the use of tax provisions, such as loss carrying.

Commentary: «Revenues were up 8.3 % for the third quarter versus the prior - year period, due primarily to higher commodity prices impacting the Company's supply chain revenues, higher same store sales in both domestic and international stores, store count growth in international markets and the positive impact of changes in foreign currency exchange ratesRevenues were up 8.3 % for the third quarter versus the prior - year period, due primarily to higher commodity prices impacting the Company's supply chain revenues, higher same store sales in both domestic and international stores, store count growth in international markets and the positive impact of changes in foreign currency exchange ratesrevenues, higher same store sales in both domestic and international stores, store count growth in international markets and the positive impact of changes in foreign currency exchange rates.»

How this value gets articulated and expressed may change significantly year - to - year and even be supplanted by another value due to a global event — while needs such as ease of use and revenue growth will remain constant.

Due to continued growth (858 % revenue growth over the last 4 years), DiscoverOrg will hire another 200 employees by the end of 2017 to support its 2,000 + customers and expanding platform of company and contact business intelligence.

The $ 20 million of revenue reportability was driven by $ 9 million of favorable revenue reportability in the first quarter of 2011, due to year - end 2010 sales associated with the launch of the company's Marriott Vacation Club Destinations program that were recognized during the first quarter of 2011, and $ 11 million of unfavorable revenue reportability in the current year quarter from strong contract sales growth that resulted in an increase in contract sales in rescission periods at the end of the quarter.

«At Games, growth was due to higher licensing revenue from the success of Star Wars: Battlefront,» a Disney earnings report from March of this year stated, «partially offset by lower Disney Infinity results.

The growth was partially offset by lower sales due to the absence of revenues associated with the release of The Magnolia Story by Chip and Joanna Gaines, Settle for More by Megyn Kelly and Hillbilly Elegy by J.D. Vance in the prior year quarter.

Xbox hardware revenue increased 14 %, primarily due to the launch of Xbox One X. Xbox software and services revenue increased 4 %, primarily due to Xbox Live revenue growth, offset in part by a decrease in revenue from the prior year launch of video games,» the report noted.

It's worth noting that NetEase's gaming segment accounted for 67 % of total revenues, a decline from 73 % in the prior year due to fast e-commerce growth in 2017.